CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,357,087 | +242.4% | 306,704 | +179.6% | 0.00% | – |
| Q2 2023 | $2,440,514 | -34.9% | 109,686 | -36.7% | 0.00% | – |
| Q1 2023 | $3,751,360 | -6.6% | 173,193 | -12.4% | 0.00% | -100.0% |
| Q4 2022 | $4,016,038 | -9.7% | 197,737 | +14.0% | 0.00% | 0.0% |
| Q3 2022 | $4,448,000 | +116.7% | 173,487 | +101.0% | 0.00% | – |
| Q2 2022 | $2,053,000 | -65.4% | 86,333 | -67.2% | 0.00% | -100.0% |
| Q1 2022 | $5,926,000 | -11.0% | 263,151 | -21.8% | 0.00% | – |
| Q4 2021 | $6,662,000 | +281.1% | 336,514 | +279.0% | 0.00% | – |
| Q3 2021 | $1,748,000 | -55.5% | 88,800 | -50.2% | 0.00% | – |
| Q2 2021 | $3,926,000 | -56.9% | 178,480 | -53.3% | 0.00% | -100.0% |
| Q1 2021 | $9,102,000 | -70.1% | 382,585 | -67.1% | 0.00% | -50.0% |
| Q4 2020 | $30,446,000 | +94.3% | 1,163,922 | +29.3% | 0.00% | -33.3% |
| Q3 2020 | $15,666,000 | +133.5% | 900,088 | +125.7% | 0.00% | +50.0% |
| Q2 2020 | $6,708,000 | +24.8% | 398,800 | -11.8% | 0.00% | 0.0% |
| Q1 2020 | $5,375,000 | +56.5% | 452,075 | +59.2% | 0.00% | +100.0% |
| Q4 2019 | $3,435,000 | -28.2% | 283,900 | -16.1% | 0.00% | -50.0% |
| Q3 2019 | $4,782,000 | -54.6% | 338,359 | -64.2% | 0.00% | +100.0% |
| Q2 2019 | $10,540,000 | +385.3% | 945,064 | +410.9% | 0.00% | – |
| Q1 2019 | $2,172,000 | -64.8% | 184,980 | -60.0% | 0.00% | -100.0% |
| Q4 2018 | $6,179,000 | -0.4% | 462,482 | +4.6% | 0.00% | 0.0% |
| Q3 2018 | $6,201,000 | +42.7% | 442,300 | +60.0% | 0.00% | 0.0% |
| Q2 2018 | $4,346,000 | -37.5% | 276,470 | -34.6% | 0.00% | -33.3% |
| Q1 2018 | $6,958,000 | +14.0% | 423,000 | +25.2% | 0.00% | +50.0% |
| Q4 2017 | $6,101,000 | +58.3% | 337,800 | +69.2% | 0.00% | 0.0% |
| Q3 2017 | $3,854,000 | +86.9% | 199,678 | +14.3% | 0.00% | +100.0% |
| Q2 2017 | $2,062,000 | +33.2% | 174,757 | +23.8% | 0.00% | 0.0% |
| Q1 2017 | $1,548,000 | -19.7% | 141,200 | -46.8% | 0.00% | 0.0% |
| Q4 2016 | $1,927,000 | +646.9% | 265,415 | +568.3% | 0.00% | – |
| Q3 2016 | $258,000 | -13.1% | 39,714 | -26.9% | 0.00% | – |
| Q2 2016 | $297,000 | -56.8% | 54,348 | -60.6% | 0.00% | – |
| Q4 2015 | $687,000 | +126.7% | 137,900 | +71.5% | 0.00% | – |
| Q3 2015 | $303,000 | -70.7% | 80,426 | -53.3% | 0.00% | – |
| Q2 2015 | $1,034,000 | +447.1% | 172,054 | +409.7% | 0.00% | – |
| Q1 2015 | $189,000 | +130.5% | 33,754 | +24.4% | 0.00% | – |
| Q4 2014 | $82,000 | +5.1% | 27,126 | -6.7% | 0.00% | – |
| Q3 2014 | $78,000 | -51.2% | 29,082 | -49.0% | 0.00% | – |
| Q2 2014 | $160,000 | -66.7% | 57,078 | -48.1% | 0.00% | – |
| Q1 2014 | $480,000 | +421.7% | 110,080 | +286.6% | 0.00% | – |
| Q4 2013 | $92,000 | +283.3% | 28,473 | +84.9% | 0.00% | – |
| Q3 2013 | $24,000 | -7.7% | 15,400 | +2.7% | 0.00% | – |
| Q2 2013 | $26,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |